prednisone has been researched along with Heart Disease, Ischemic in 4 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Omeprazole is a drug widely used in the treatment of gastroesophageal reflux disease and peptic ulcer disease." | 8.82 | [Acute interstitial nephritis associated with omeprazole therapy]. ( Calvo, C; García, H; Hernández-Jaras, J; Maduell, F; Rovira, RE; Torregrosa, E, 2004) |
| " Omeprazole is a drug widely used in the treatment of gastroesophageal reflux disease and peptic ulcer disease." | 4.82 | [Acute interstitial nephritis associated with omeprazole therapy]. ( Calvo, C; García, H; Hernández-Jaras, J; Maduell, F; Rovira, RE; Torregrosa, E, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Samura, B | 1 |
| Versaci, F | 1 |
| Gaspardone, A | 1 |
| Tomai, F | 1 |
| Ribichini, F | 1 |
| Russo, P | 1 |
| Proietti, I | 1 |
| Ghini, AS | 1 |
| Ferrero, V | 1 |
| Chiariello, L | 1 |
| Gioffrè, PA | 1 |
| Romeo, F | 1 |
| Crea, F | 1 |
| Torregrosa, E | 1 |
| Rovira, RE | 1 |
| Calvo, C | 1 |
| Hernández-Jaras, J | 1 |
| Maduell, F | 1 |
| García, H | 1 |
| Podbielski, FJ | 1 |
| el Chaer, R | 1 |
| Massad, MG | 1 |
| Chami, YG | 1 |
| Nawas, S | 1 |
| O'Leary, P | 1 |
| Benedetti, E | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Erythrocyte-Mediated Drug Delivery for the Prevention of Restenosis After Coronary Artery Stent Implantation:TROY-Study[NCT00484965] | Phase 4 | 100 participants (Anticipated) | Interventional | 2007-07-31 | Not yet recruiting | ||
| Clinical and Angiographic Outcome of Patients Treated With Bare Metal Stent (BMS) Implantation Compared With Drug Eluting Stents or BMS Plus Systemic Prednisone Therapy. A Randomized, Multicentre Study.[NCT00369356] | Phase 2/Phase 3 | 375 participants (Actual) | Interventional | 2006-10-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for prednisone and Heart Disease, Ischemic
| Article | Year |
|---|---|
[Acute interstitial nephritis associated with omeprazole therapy].
Topics: Acute Disease; Aged; Combined Modality Therapy; Enzyme Inhibitors; Female; Gastroesophageal Reflux; | 2004 |
1 trial available for prednisone and Heart Disease, Ischemic
| Article | Year |
|---|---|
Immunosuppressive Therapy for the Prevention of Restenosis after Coronary Artery Stent Implantation (IMPRESS Study).
Topics: Adult; Aged; Aged, 80 and over; Blood Vessel Prosthesis Implantation; C-Reactive Protein; Coronary A | 2002 |
Immunosuppressive Therapy for the Prevention of Restenosis after Coronary Artery Stent Implantation (IMPRESS Study).
Topics: Adult; Aged; Aged, 80 and over; Blood Vessel Prosthesis Implantation; C-Reactive Protein; Coronary A | 2002 |
Immunosuppressive Therapy for the Prevention of Restenosis after Coronary Artery Stent Implantation (IMPRESS Study).
Topics: Adult; Aged; Aged, 80 and over; Blood Vessel Prosthesis Implantation; C-Reactive Protein; Coronary A | 2002 |
Immunosuppressive Therapy for the Prevention of Restenosis after Coronary Artery Stent Implantation (IMPRESS Study).
Topics: Adult; Aged; Aged, 80 and over; Blood Vessel Prosthesis Implantation; C-Reactive Protein; Coronary A | 2002 |
2 other studies available for prednisone and Heart Disease, Ischemic
| Article | Year |
|---|---|
GALECTIN-3 AS A PROGNOSTIC BIOMARKER IN PATIENTS WITH NON-HODGKIN LYMPHOMA.
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Arrhyt | 2015 |
What makes a coronary myocardial bridge symptomatic?
Topics: Administration, Oral; Aged; Bronchodilator Agents; Chest Pain; Coronary Angiography; Coronary Vessel | 1998 |